🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Miguel A. Villalona‐Calero

University of California, Irvine

ORCID: 0000-0002-1991-5070
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers”.

A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3060
N/A
0.668DataRank · unranked
12 citations

Rachel K. Kim, Linda S. Ahn, Andrew J. Plodkowski, Ai Ni, Mark T.A. Donoghue +10 more

Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-0324
N/A
0.551DataRank · unranked
12 citations

Rui Ma, Anthony G. Mansour, Christian Bustillos, Zhiyao Li, Zhenlong Li +8 more

Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07551-z
N/A
0.385DataRank · unranked
12 citations

H. Boutrid, Mahmoud Kassem, Mahmoud Abdel‐Rasoul, Cynthia Timmers, Maryam B. Lustberg +19 more

Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107083
N/A
0DataRank · unranked
0 citations

Miguel A. Villalona‐Calero, Edward M. Newman, Paul Frankel, Carolyn E. Behrendt

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study

The Oncologist(2020)10.1634/theoncologist.2020-0039
N/A
0DataRank · unranked
14 citations

Daniel G. Stover, Maryam B. Lustberg, Abigail B. Shoben, Meng Zhao, Ewa Mrózek +23 more

A novel HLA-DQB2::MET gene fusion variant in lung adenocarcinoma with prolonged response to tepotinib: a case report

Translational Lung Cancer Research(2024)10.21037/tlcr-24-34
N/A
0DataRank · unranked
3 citations

Isa Mambetsariev, Jeremy Fricke, Razmig Babikian, Shaira Therese Dingal, Farhad Mazdisnian +6 more

Erlotinib in African Americans With Advanced Non–Small Cell Lung Cancer: A Prospective Randomized Study With Genetic and Pharmacokinetic Analyses

UNC Libraries(2020)10.17615/05ak-3t14
N/A
0DataRank · unranked
0 citations

You-Han Gao, L. Wei, J. Li, D. Wang, Mark A. Socinski +12 more

A phase 1 trial of umbilical cord blood–derived tumor-reactive PD-L1+ natural killer cells engineered to express soluble IL-15 (TRACK-NK) in patients with non–small-cell lung cancer (NSCLC) refractory to PD-1/PD-L1 inhibitors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps2665
N/A
0DataRank · unranked
4 citations

Stephen J. Forman, Joycelynne Palmer, Timothy W. Synold, Lei Tian, Ting Lu +14 more